BioLife Sciences Inc. Files Form 1-A with the Securities and Exchange Commission (SEC) to Raise Capital Under a Tier I Regulation A+ Offering HENDERSON, NV, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences Inc. (OTC: BLFE) (the “Company” or “BioLife”), announced today that it has filed Form 1-A with the Securities and...